MEDIUM confidence: 100% data completeness, but the composite (60) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-08-23.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Avg target $153 (last qtr, 9 analysts) → $148 (last mo, 3) (-3.3%).
Buy-rated share 75% → 81% over ~3 months (+6pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Oct 2026 | $2.72 | $2.76 | +1.5% |
| Jul 2026 | $2.61 | $2.63 | +0.8% |
| Apr 2026 | $2.46 | $2.57 | +4.5% |
| Jan 2026 | $2.49 | $2.52 | +1.2% |
| Oct 2025 | $2.36 | $2.62 | +11.0% |
| Jul 2025 | $2.25 | $2.28 | +1.3% |
| Apr 2025 | $2.05 | $2.09 | +2.0% |
| Jan 2025 | $2.12 | $2.08 | -1.9% |
Net insider -$11.9M over 180 days (0 open-market buys, 10 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $1.9B— | $2.6B+37.4% | $3.9B+52.1% | $4.5B+13.6% | $4.6B+3.5% |
| EPS (dil.) | $6.10— | $7.92+29.8% | $8.18+3.3% | $8.33+1.8% | $9.52+14.3% |
| Free Cash Flow | $1.2B— | $2.1B+77.7% | $1.4B-31.0% | $1.4B-0.9% | $1.5B+6.4% |
| Gross Margin | 97.2% | 86.6%-10.7pp | 61.8%-24.7pp | 53.4%-8.4pp | 59.0%+5.6pp |
| Operating Margin | 55.9% | 54.4%-1.5pp | 37.0%-17.4pp | 33.1%-3.9pp | 37.2%+4.1pp |
| Net Margin | 46.2% | 43.5%-2.7pp | 29.4%-14.1pp | 26.0%-3.4pp | 28.6%+2.6pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth below the analyst consensus of 9.5%/yr (revenue basis).
Base free cash flow $1.4B (avg FY2023–FY2025; latest year $1.5B) · equity value $17.9B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 60 indicates a moderately attractive stock, driven by strong momentum and low risk. EWBC scores high on momentum, with a 12-month return of 31.0% and a bullish 50-day versus 200-day moving average trend. In contrast, the stock's growth and value categories are more subdued, with a P/E of 12.3 and revenue growth of 3.5%. The short-term score is slightly higher than the long-term score, suggesting some near-term optimism.